Published in Biochem Pharmacol on July 01, 1966
Studies on the interactions of guanethidine and bretylium with noradrenaline stores. Br J Pharmacol Chemother (1967) 0.98
Modulation of noradrenaline incorporation by nerve activities in the rat submaxillary gland. J Physiol (1969) 0.75
Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci (1982) 3.02
Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol (1993) 1.92
Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. Life Sci (1986) 1.80
Release of histamine from stomach by vagus-stimulating drugs: association with gastric acid secretion. Fed Proc (1966) 1.67
Transport and storage of biogenic amines. Annu Rev Pharmacol (1972) 1.28
Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol (1990) 1.26
The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur J Pharmacol (1989) 1.24
In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther (1991) 1.24
VAMPIRE: Vessel assessment and measurement platform for images of the REtina. Conf Proc IEEE Eng Med Biol Soc (2011) 1.21
The mode of sodium dependency of the adrenergic neuron amide carrier. Evidence for a second, sodium-dependent, optically specific and reserpine-sensitive system. J Pharmacol Exp Ther (1969) 1.20
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur J Pharmacol (1989) 1.17
Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci U S A (1977) 1.16
A potent and selective agonist for NK-2 tachykinin receptor. Peptides (1989) 1.14
A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pump. Biochem Pharmacol (1967) 1.09
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase. Antiviral Res (1996) 1.09
On the inability to produce supersensitivity to catecholamines in intestinal smooth muscle. J Pharmacol Exp Ther (1969) 1.06
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther (1988) 1.03
Studies in vitro of amine uptake mechanisms in heart. Biochem Pharmacol (1966) 1.03
Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. Eur J Pharmacol (1980) 1.00
Specific binding of reserpine. Association with norepinephrine depletion. Biochem Pharmacol (1969) 1.00
AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther (1987) 1.00
A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. Eur J Pharmacol (1990) 0.99
Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: effect of neuromuscular blocking agents on the activity of the external urethral sphincter. J Pharmacol Methods (1991) 0.98
Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem Pharmacol (1980) 0.98
Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol (1986) 0.98
Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev (1995) 0.97
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors. J Auton Pharmacol (1991) 0.97
(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists. J Med Chem (1984) 0.97
Trabecular architecture in women and men of similar bone mass with and without vertebral fracture: II. Three-dimensional histology. Bone (2000) 0.96
Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol (1991) 0.96
Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol (1994) 0.96
In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist. Eur J Pharmacol (1993) 0.96
Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Br J Pharmacol (1992) 0.95
In vivo monoamine oxidase inhibition by d-amphetamine. Biochem Pharmacol (1980) 0.94
The mode of potassium action on the adrenergic neuron amine transport system. Life Sci (1969) 0.94
Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors. Gastroenterology (1992) 0.94
Amine uptake and storage mechanisms in the corpus striatum of rat and rabbit. J Pharmacol Exp Ther (1971) 0.93
The relative functional availability of brain noradrenaline and dopamine storage pools. J Pharm Pharmacol (1977) 0.93
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium. Cell Death Differ (2006) 0.91
Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo. J Pharmacol Exp Ther (1993) 0.91
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents. Br J Pharmacol (1976) 0.91
Tachykinin receptors and intestinal motility. Can J Physiol Pharmacol (1997) 0.89
Further studies on the response of the guinea-pig isolated bronchus to endothelins and sarafotoxin S6b. Eur J Pharmacol (1990) 0.89
The use of optical flow to characterize muscle contraction. J Neurosci Methods (2001) 0.89
Receptor binding profile of Otilonium bromide. Pharmacol Res (1998) 0.89
Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter. Biochem Pharmacol (1974) 0.89
Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Br J Pharmacol (1995) 0.88
Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.88
Subsensitivity of cardiac beta-adrenoceptors in renal hypertensive rats. J Cardiovasc Pharmacol (1980) 0.88
Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT. Bone (2005) 0.87
Tachykinin receptors in the circular muscle of the guinea-pig ileum. Br J Pharmacol (1990) 0.86
MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. Br J Pharmacol (1998) 0.86
The possible role of ATP and PACAP as mediators of apaminsensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon. Br J Pharmacol (1996) 0.86
NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype. Eur J Pharmacol (1991) 0.86
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress. J Vasc Res (2004) 0.86
Motor response of the human isolated colon to capsaicin and its relationship to release of vasoactive intestinal polypeptide. Neuroscience (1990) 0.86
NK-2 receptor agonists and antagonists. Ann N Y Acad Sci (1991) 0.85
Multiple sources of calcium for contraction of the human urinary bladder muscle. Br J Pharmacol (1989) 0.85
On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin. Biochem Pharmacol (1969) 0.85
Effect of endothelin-1, endothelin-3 and C-terminal hexapeptide, endothelin (16-21) on motor activity in rats. Neuropeptides (1990) 0.85
Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat. J Cardiovasc Pharmacol (2000) 0.85
Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. J Cardiovasc Pharmacol (1992) 0.84
Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain. J Pharmacol Exp Ther (1973) 0.84
Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons. Brain Res Bull (1984) 0.84
The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase. Pharmacol Rev (1966) 0.84
Direct evidence for the involvement of vasoactive intestinal polypeptide in the motor response of the human isolated ileum to capsaicin. Eur J Pharmacol (1990) 0.83
The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. J Urol (1990) 0.83
Distribution of clozapine in the rat: localization in lung. J Pharmacol Exp Ther (1978) 0.83
Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J Pharmacol Exp Ther (1988) 0.83
Further studies on the nature of persistent reserpine binding: evidence for reversible and irreversible binding. Biochem Pharmacol (1971) 0.83
The effect of MK-801 on the micturition reflex in anesthetized rats. Eur J Pharmacol (1990) 0.82
Modulation by stereoselective inhibition of cyclo-oxygenase of electromechanical coupling in the guinea-pig isolated renal pelvis. Br J Pharmacol (1995) 0.82
Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J Pharm Pharmacol (1976) 0.82
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity. Oncogene (2011) 0.82
An integrated simulator for surgery of the petrous bone. Stud Health Technol Inform (2001) 0.81
Atropine inhibits thromboxane A2 generation in isolated lungs of the guinea-pig. Br J Pharmacol (1980) 0.81
Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.81
Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans. Drug Metab Dispos (1993) 0.81
The functional state of sympathetic nerves in spontaneously diabetic mice. Diabetes (1978) 0.81
Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine. Eur J Pharmacol (1982) 0.81
The reserpine receptor. Life Sci (1978) 0.81
Role of muscarinic receptor subtypes in the regulation of migrating myoelectric complex in the dog. Gastroenterology (1989) 0.80
Characteristics of storage and release of metaraminol in the rat heart. Biochem Pharmacol (1972) 0.80
Effects of nucleus basolateralis amygdalae neurotoxic lesions on aversive conditioning in the rat. Physiol Behav (1991) 0.80
Differences in norepinephrine and dopamine neurotransmitter storage systems. Brain Res Bull (1979) 0.80
Optical specificity of monoamine oxidase. Life Sci (1966) 0.80
Facilitation of reflex micturition by intravesical administration of [beta Ala8]-neurokinin A (4-10), a selective NK-2 tachykinin receptor agonist. J Urol (1991) 0.80
In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist. Eur J Pharmacol (1990) 0.80
Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brain. Life Sci (1979) 0.80
Involvement of tachykinin NK1 receptors in plasma protein extravasation induced by tachykinins in the guinea pig upper airways. Neuropeptides (1997) 0.79
Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist. Br J Pharmacol (1995) 0.79
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J Pharmacol Exp Ther (1993) 0.79
Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation. Brain Res Bull (1981) 0.79
On the nature of the adrenergic neuron extragranular amine binding site. J Neural Transm (1974) 0.79